相关实验视频

Updated: May 28, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

p27Kip1和瘤:在MEN4和乳腺癌中发现的CDKN1B变体的特征

Debora Bencivenga¹, Emanuela Stampone¹, Jahanzaib Azhar¹

¹Department of Precision Medicine, University of Campania "L. Vanvitelli", Via Luigi De Crecchio, 7, 80138 Naples, Italy.

|February 12, 2025

概括

在p27Kip1基因 (CDKN1B) 的突变增加癌细胞的生长和运动. 这些CDKN1B突变改变了蛋白质的功能,定位和与细胞循环调节者的相互作用,导致MEN4和各种癌症的不受控制的增殖.

科学领域:

分子生物学分子生物学
细胞生物学细胞生物学
遗传学是一个遗传学.

背景情况:

p27Kip1是一个关键的细胞循环调节器,控制CDK活动和细胞增殖.
像p27Kip1这样的内在非结构蛋白经历了翻译后的修改,影响了它们的功能和定位.
生殖线和体内CDKN1B突变与MEN4,白血病,神经内分泌瘤和癌症有关.

研究的目的:

研究在MEN4和癌症患者中发现的四种特定CDKN1B突变 (p.P117S,p.P133T,p.Q163*,p.E171*) 的功能影响.
分析这些突变如何影响p27Kip1蛋白的稳定性,局部化,酸化和与细胞循环机制的相互作用.
阐明CDKN1B突变有助于增加细胞增殖和移动性的机制.

主要方法:

乳腺癌细胞系感染野生型和突变的CDKN1B构造物.
对细胞生长和移动性的分析.
评估蛋白质酸化,细胞局部化和降解途径.
评估p27Kip1与环林/CDK复合物的结合效率.

主要成果:

与野生类型p27Kip1.1.相比,所有研究的CDKN1B突变导致细胞生长和运动率的增加.
突变的p27Kip1蛋白显示出改变的酸化模式,不同的局部化和修改的降解机制.
一个特定的区域被确定为p27Kip1.1.的 lysosome-dependent降解的潜在关键区域.
突变p27Kip1抑制细胞增殖的能力降低与结合Cyclin/CDK复合物的减少有关.

结论:

研究的CDKN1B突变破坏了p27Kip1的细胞循环抑制功能,促进了癌症的进展.
变化的蛋白质稳定性,局部化和相互作用有助于这些CDKN1B突变的致癌潜力.
了解这些机制,可以了解与CDKN1B变异相关的癌症的治疗策略.

关键词:

这就是CDKN1B.癌症癌症癌症癌症癌症细胞循环中的细胞循环.细胞移动性的细胞移动性 p27Kip1 在线阅读瘤抑制基因的基因抑制器

更多相关视频

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

M-Cdk Drives Transition Into Mitosis

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...